Ati cautat: cancer hepatic
Protocol terapeutic: L016C – : DCI INTERFERON ALFA 2B (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L004C – DCI BEVACIZUMABUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L003C – DCI FULVESTRANTUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: G005N – DCI LEVONORGESTRELUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: G002N – DCI ESTRADIOLUM VALERAT + DIENOGEST (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: A001E – DCI ORLISTATUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
ANPP respinge ultimele recomandari in tratamentul hepatitei C
17 molecule noi pentru tratamentul bolilor rare nu pot intra in lista de medicamente compensate
